Scarica l'app Stockscreener
5.18
5.71%
0.28
Dopo l'orario di chiusura:
5.36
0.18
+3.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AURA Giù?
Forum
Previsione
Precedente Chiudi:
$4.90
Aprire:
$4.53
Volume 24 ore:
482.24K
Relative Volume:
1.81
Capitalizzazione di mercato:
$291.56M
Reddito:
-
Utile/perdita netta:
$-76.41M
Rapporto P/E:
-2.6979
EPS:
-1.92
Flusso di cassa netto:
$-64.56M
1 W Prestazione:
-10.69%
1M Prestazione:
-7.00%
6M Prestazione:
-45.30%
1 anno Prestazione:
-30.93%
Intervallo 1D:
$4.345
$5.38
Intervallo di 1 settimana:
$4.345
$5.92
Portata 52W:
$4.345
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Nome
Aura Biosciences Inc
Settore
Industria
Telefono
(617)500-8864
Indirizzo
80 GUEST STREET, BOSTON
Confronta AURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
5.18 | 291.56M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.38 | 110.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.99 | 59.13B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
561.75 | 34.75B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
283.40 | 33.69B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
225.77 | 25.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-07-19 | Iniziato | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Borsa (AURA) Ultime notizie
Aura Biosciences announces common stock, warrant offering, no amount given - TipRanks
Aura Biosciences Prices $75 Million Offering of Shares, Warrants - marketscreener.com
Aura Biosciences sets terms for $75 million public offering - Investing.com
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewswire
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga
Aura Biosciences Launches Proposed Public Offering of Shares, Warrants - marketscreener.com
Aura Biosciences (AURA) Initiates Public Offering with Multiple Financial Managers | AURA Stock News - GuruFocus
Aura Biosciences Appoints New Chief Financial Officer - TipRanks
Aura Biosciences Announces Proposed Public Offering Of Common Stock And Warrants - marketscreener.com
Aura Biosciences, Inc. SEC 10-Q Report - TradingView
Aura Biosciences Enrolls First Patient in Phase 1b/2 Trial of Bel-sar for Non-Muscle-Invasive Bladder Cancer and Strengthens Leadership Team with New Appointment - Nasdaq
Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewswire
Major Cancer Therapy Developer Aura Biosciences Announces Strategic Public Offering with Top Wall Street Banks - Stock Titan
Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Aura Biosciences Hits Major Milestone in Bladder Cancer Trial, Reveals Strong Pipeline Progress - Stock Titan
Dimensional Fund Advisors LP Buys 73,062 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
(AURA) Trading Advice - news.stocktradersdaily.com
Barclays PLC Grows Stock Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Analysts Set Aura Biosciences, Inc. (NASDAQ:AURA) Price Target at $22.75 - Defense World
Wells Fargo & Company MN Buys 5,930 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Clinical-Stage Biotech Aura Biosciences Lines Up 3 Key Investor Conferences: What to Expect - Stock Titan
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 37.3% in April - Defense World
(AURA) Proactive Strategies - news.stocktradersdaily.com
Aura Biosciences, Inc. (NASDAQ:AURA) Shares Purchased by JPMorgan Chase & Co. - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Position Increased by Geode Capital Management LLC - Defense World
Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 19.3% in March - Defense World
Vanguard Group Inc. Acquires 112,296 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock By Investing.com - Investing.com India
Aura Biosciences SVP sells $4,924 in stock By Investing.com - Investing.com India
Aura Biosciences executive sells $39,319 in stock By Investing.com - Investing.com Canada
Aura Biosciences executive sells $39,319 in stock - Investing.com Australia
Aura Biosciences SVP sells $4,924 in stock - Investing.com
Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock - Investing.com
Wellington Management Group LLP Has $1.08 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
American Century Companies Inc. Has $392,000 Stake in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Q1 EPS Estimate for Aura Biosciences Decreased by Analyst - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Aura Biosciences stock hits 52-week low at $5.05 - Investing.com Australia
Aura Biosciences stock hits 52-week low at $5.05 By Investing.com - Investing.com South Africa
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential? - Insider Monkey
10 Small Cap Stocks with Huge Upside Potential - Insider Monkey
Aura Biosciences expands board with oncology leader By Investing.com - Investing.com South Africa
Aura Biosciences Appoints Teresa Bitetti To Board - citybiz
Aura Biosciences Announces Appointment Of Teresa Bitetti To Board Of Directors - MarketScreener
Aura Biosciences Expands Board with New Director Appointment - TipRanks
Aura Biosciences expands board with oncology leader - Investing.com
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - GlobeNewswire
Aura Biosciences Inc Azioni (AURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):